← Back to Search

Local Anesthetic

Erector Spinae Nerve Block for Thoracic Surgery

Phase 4
Waitlist Available
Led By Charles Luke, MD
Research Sponsored by Charles Luke
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0-120 hours post-operative
Awards & highlights

Study Summary

This trial will compare the efficacy, safety, and side-effect profile of continuous erector spinae plane analgesia (ESP) versus continuous paravertebral analgesia (PVB) for video-assisted thoracic surgery (VATS).

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0-120 hours post-operative
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0-120 hours post-operative for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient Reported Pain Scores
Total Opioid Consumption
Secondary outcome measures
Amount Achieved on Incentive Spirometer
Averaged Total of Narcotic Usage
Length of Hospital Stay
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Paravertebral Nerve BlockExperimental Treatment1 Intervention
Paravertebral nerve block
Group II: Erector Spinae Nerve BlockExperimental Treatment1 Intervention
Erector Spinae nerve block
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Paravertebral nerve block
2019
Completed Phase 4
~40
Erector Spinae nerve block
2019
Completed Phase 4
~40

Find a Location

Who is running the clinical trial?

Charles LukeLead Sponsor
Neal Shah, MDLead Sponsor
Nicholas Schott, MDStudy DirectorUniversity of Pittsburgh

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What risks do the patients involved in this treatment regimen face?

"The safety profile of this treatment has been thoroughly assessed, and is thus assigned a score of 3. This Phase 4 trial ensures the approved status for patient use."

Answered by AI

Are there still opportunities for patients to partake in this experiment?

"Affirmative. Clinicaltrials.gov confirms that this medical trial, initially posted on March 11th 2019 is presently recruiting patients. 60 participants from 1 site need to be enrolled in the study."

Answered by AI

What is the maximum capacity for enrollees in this trial?

"Affirmative. The particulars of this medical trial, which was published on March 11th 2019, are available on clinicaltrials.gov and the study is currently looking for 60 participants from a single research centre."

Answered by AI

What are the core goals of this medical experiment?

"This clinical trial has one primary objective: to measure total opioid consumption over a 24 hour period after the catheter is removed. The secondary objectives include determining length of hospital stay, amount achieved on incentive spirometer device (mL), and any reported adverse events or complications with nerve block catheter placement such as pneumothorax, infections, bleeding, and local anesthetic toxicity."

Answered by AI
~6 spots leftby Mar 2025